Showing results (1-10 of 1,264) with videos related to

Sort By:
Pageof 127
CJC Open|December 13, 2021
Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection FractionNancy Luo, Christopher M O'Connor, Karen Chiswell, et al.
Circulation|September 6, 2023
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical TrialDerek S Chew, Yanhong Li, Robert Bigelow, et al.
Journal of Cardiac Failure|March 18, 2022
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA RegistryStephen J Greene, Justin A Ezekowitz, Kevin J Anstrom, et al.
ESC Heart Failure|October 22, 2024
Projecting the benefit of vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA trialVeraprapas Kittipibul, Robert J Mentz, Rebecca Young, et al.
American Heart Journal|March 3, 2015
A reappraisal of loop diuretic choice in heart failure patientsJonathan Buggey, Robert J Mentz, Bertram Pitt, et al.
Journal of the American Heart Association|November 8, 2021
Blood Pressure and Safety Events With Vericiguat in the VICTORIA TrialCarolyn S P Lam, Hillary Mulder, Yuri Lopatin, et al.
JAMA Cardiology|November 13, 2020
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA TrialCarolyn S P Lam, Anna Giczewska, Karen Sliwa, et al.
Journal of Cardiac Failure|August 25, 2024
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction TrialCynthia M Westerhout, Sarah Rathwell, Kevin J Anstrom, et al.
Journal of Cardiac Failure|June 18, 2023
Classification of Heart Failure Events by Severity: Insights From the VICTORIA TrialG Michael Felker, Rebecca North, Hillary Mulder, et al.
JACC. Heart Failure|October 17, 2017
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA TrialPaul W Armstrong, Lothar Roessig, Mahesh J Patel, et al.
Pageof 127